56 reports

ONE ICE SYSTEM REFERS TO ONE CONSOLE.

  • Antimalarials
  • Respiratory Monitoring
  • Market Size
  • Biosense Webster, Inc.
  • Boston Scientific Corporation
  • 9.3.4 ERTUGLIFLOZIN

DESPITE ITS LOW COST, GASTROINTESTINAL (GI) SIDE EFFECTS ARE VERY COMMON WITH ACARBOSE, WHICH HAS PREVENTED ITS WIDESPREAD USE.

  • Antimalarials
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

There are three types of vaccines: ##.

  • Antimalarials
  • North America
  • United States
  • Allergan plc
  • Merck & Co., Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Antimalarials
  • Drug Discovery And Development
  • World
  • GlaxoSmithKline plc
  • Pfizer Inc.

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation

THE CLAIMANTS PURPORT THAT XARELTO IS HARMFUL TO ONE' S HEALTH AND CAN CAUSE SERIOUS INJURIES, SUCH AS DEATH AND/ OR GASTROINTESTINAL OR CEREBRAL HEMORRHAGING (BAYER, 2015A).

  • Antimalarials
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Sanofi S.A.
  • PRODUCTS UNDER DEVELOPMENT BY UNIVERSITIES/INSTITUTES, H1 2018 (CONTD..1), H1 2018
  • MALARIA - PIPELINE BY BHARAT BIOTECH LTD, H1 2018

Malaria - Overview Malaria - Therapeutics Development PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR MALARIA, H## 2018 NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR MALARIA, H## 2018 Pre-Registration ## ## Phase III ## ## Phase II ## ## Phase I ## ## Preclinical ## ## Discovery ## ## Unknow

  • Antimalarials
  • Malaria
  • Vaccine
  • United States
  • Sanaria Inc.
  • PRODUCTS UNDER DEVELOPMENT BY UNIVERSITIES/INSTITUTES, H2 2017 (CONTD..1), H2 2017
  • MALARIA - PIPELINE BY BHARAT BIOTECH INTERNATIONAL LTD, H2 2017

Malaria - Overview Malaria - Therapeutics Development PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR MALARIA, H## 2017 NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR MALARIA, H## 2017 Pre-Registration ## ## Phase III ## ## Phase II ## ## Phase I ## ## Preclinical ## ## Discovery ##

  • Antimalarials
  • Malaria
  • Vaccine
  • United States
  • Sanaria Inc.

Each security is composed of one ordinary share and one warrant.

  • Antimalarials
  • Dementia
  • Therapy
  • Europe
  • AB Science SA
  • A-5425 - DRUG PROFILE
  • Substance-K Receptor (SKR or NK-2 Receptor or Neurokinin A Receptor or Tachykinin Receptor 2 or TACR2) - Drug Profiles

It blocks the effects of tachykinins in the respiratory, gastrointestinal and urogenital tract.

  • Antimalarials
  • Hospital
  • World
  • Product Initiative
  • Takeda Pharmaceutical Company Limited

One unit is one oximeter sensor.

  • Respiratory Monitoring
  • Sensor
  • United States
  • Company
  • GlobalData's company

The molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Antimalarials
  • Chronic Disease
  • World
  • Product Initiative
  • Pharmaxis Ltd

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Antimalarials
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • Zydus Cadila Healthcare Enters into Agreement with Medicines for Malaria Venture

GlobalData Medicines for Malaria Venture reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Antimalarials
  • Malaria
  • Switzerland
  • United States
  • Company Operations

It offers drugs to treat gastrointestinal (GI) breakdown from cardiogenic shock following heart surgery, septic shock, hemorrhagic and hypovolemic shock.

  • Antimalarials
  • Therapy
  • United States
  • World
  • Product Initiative
  • Respiratory Measurement Devices Companies and Product Overview

One unit is one Capnograph.

  • Antimalarials
  • Drug Discovery And Development
  • Respiratory Monitoring
  • United States
  • Masimo Corporation

Growth in molecular biology lines was driven by the ongoing fast-paced development of FilmArray®, and in particular the Gastrointestinal and Meningitis/ Encephalitis panels.

  • Antimalarials
  • Heart Failure
  • In Vitro Diagnostic Reagent
  • United States
  • bioMerieux S.A.

The company' s franchise areas in research include neurology, oncology, vascular and immunological reaction, gastrointestinal disorders, and musculoskeletal diseases.

  • Antimalarials
  • Malaria
  • World
  • Product Initiative
  • Eisai Co., Ltd.

It discovers, develops and commercializes small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders.

  • Antimalarials
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Antimalarials
  • Clinical Trial
  • Neurology
  • World
  • Product Initiative

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Antimalarials
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative

Gastrointestinal ## ## Genito Urinary System And Sex Hormones ## ## Oncology ## ## NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATION, H## 2016 TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY M MEMBER ## (LONG TRANSIENT RECEPTOR POTENTIAL CHANNEL ## OR TRANSIENT RECE

  • Antimalarials
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • A-5425 - Drug Profile
  • Substance K Receptor (NK2 Receptor or Neurokinin A Receptor or Tachykinin Receptor 2 or NK2R or TACR2) - Drug Profiles

The company provides development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders.

  • Antimalarials
  • Therapy
  • Vaccine
  • World
  • Product Initiative

Levofloxacin recipients received ## mg once daily on Days ##-##.

  • Antimalarials
  • Healthcare
  • World
  • Demand
  • Product Initiative

The company offers APIs in the therapeutic areas of antibiotic, oncology, cardiovascular, urology, gastrointestinal, antiviral and respiratory, among others.

  • Antimalarials
  • Therapy
  • Vaccine
  • United States
  • World

Researchers identified ##-[##-fluoro-##-(##H-pyrazol-##-yl)phenyl]-##-methoxy-##-(##-phenyl-##H-pyrazol-##yl)pyridazin-##(##H)-one (##h).

  • Antimalarials
  • Therapy
  • United States
  • World
  • Pfizer Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Antimalarials
  • Drug Discovery And Development
  • Infectious Disease
  • World
  • GlaxoSmithKline plc

This report is a licensed product and is not to be photocopied DesignMedix, Inc. has promising clinical drug candidates for ## major therapeutic areas, Gastrointestinal and Infectious Disease.

  • Antimalarials
  • Pathology
  • United States
  • Company Operations
  • DesignMedix

The study also showed that the main side effects of ibudilast were gastrointestinal and headaches.

  • Antimalarials
  • Pharmaceutical
  • United States
  • Product Initiative
  • MediciNova, Inc.

Parion Sciences develops ENaC blockers which are used to treat lung, mouth, nose and the gastrointestinal tract.

  • Antimalarials
  • Respiratory Monitoring
  • Therapy
  • United States
  • GlobalData's company